As the Australian market enters Week 4 of January 2026, it remains relatively stable after a series of gains, with global attention focused on geopolitical developments and upcoming local employment data. For investors exploring beyond well-known companies, penny stocks—often representing smaller or newer firms—continue to present intriguing opportunities. While the term may seem outdated, these stocks can still offer significant value when backed by strong financials and growth potential.

Top 10 Penny Stocks In Australia

Name Share Price Market Cap Financial Health Rating EZZ Life Science Holdings (ASX:EZZ) A$1.79 A$84.21M ★★★★★★ Dusk Group (ASX:DSK) A$0.94 A$58.53M ★★★★★★ IVE Group (ASX:IGL) A$2.89 A$445.46M ★★★★★☆ MotorCycle Holdings (ASX:MTO) A$3.00 A$221.59M ★★★★★★ Pureprofile (ASX:PPL) A$0.05 A$58.49M ★★★★★★ Veris (ASX:VRS) A$0.072 A$38.91M ★★★★★★ West African Resources (ASX:WAF) A$3.42 A$3.91B ★★★★★★ Service Stream (ASX:SSM) A$2.18 A$1.34B ★★★★★★ EDU Holdings (ASX:EDU) A$0.855 A$123.06M ★★★★★☆ MaxiPARTS (ASX:MXI) A$2.17 A$120.53M ★★★★★★

Click here to see the full list of 412 stocks from our ASX Penny Stocks screener.

Below we spotlight a couple of our favorites from our exclusive screener.

Appen

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Appen Limited is an AI lifecycle company offering data sourcing, annotation, and model evaluation solutions across Australia, the United States, and globally, with a market cap of A$302.80 million.

Operations: Appen's revenue is primarily derived from its Corporate segment at $1.24 billion, followed by New Markets at $126.84 million and Global Services at $96.93 million.

Market Cap: A$302.8M

Appen Limited, with a market cap of A$302.80 million, is trading at a significant discount compared to its estimated fair value. Despite being unprofitable and having negative return on equity, the company has no debt and maintains sufficient cash runway for over three years based on current free cash flow. Its short term assets exceed both short and long term liabilities, providing some financial stability. However, the management team is relatively inexperienced with an average tenure of two years, which may impact strategic direction as it seeks to capitalize on forecasted earnings growth of 68.24% annually.

Take a closer look at Appen's potential here in our financial health report. Learn about Appen's future growth trajectory here.ASX:APX Debt to Equity History and Analysis as at Jan 2026

Calix

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Calix Limited is an environmental technology company offering industrial solutions for global decarbonisation and sustainability challenges across multiple regions, with a market cap of A$299.65 million.

Story Continues

Operations: The company's revenue segments include LEILAC generating A$3.84 million, Suspro contributing A$0.01 million, and Magnesia accounting for A$24.32 million.

Market Cap: A$299.65M

Calix Limited, with a market cap of A$299.65 million, is navigating the challenges of being unprofitable while operating in the environmental technology sector. The company has a seasoned management team but an inexperienced board, which may influence strategic decisions. Despite its high volatility and negative return on equity (-23.01%), Calix's short-term assets cover both short and long-term liabilities. Recent developments include a Joint Development Agreement with Rio Tinto to support its Zero Emissions Steel Technology demonstration plant, potentially bolstering Calix's position in sustainable steel production if successful milestones are achieved. However, cash runway concerns remain as it continues to reduce free cash flow at historical rates.

Get an in-depth perspective on Calix's performance by reading our balance sheet health report here. Gain insights into Calix's outlook and expected performance with our report on the company's earnings estimates.ASX:CXL Financial Position Analysis as at Jan 2026

Neometals

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Neometals Ltd focuses on developing and commercializing sustainable processing solutions for recycling and recovering critical materials from waste streams in Australia, with a market cap of A$59.33 million.

Operations: Neometals Ltd does not report distinct revenue segments.

Market Cap: A$59.33M

Neometals Ltd, with a market cap of A$59.33 million, is pre-revenue and currently unprofitable, facing challenges such as a negative return on equity and less than one year of cash runway. Despite these hurdles, the company maintains a strong financial position with short-term assets exceeding both short- and long-term liabilities. Neometals is debt-free and has not experienced significant shareholder dilution recently. The board of directors is seasoned; however, the management team lacks experience with an average tenure of 1.2 years. Recent board changes include the appointment of Gregory Evans as an Independent Non-Executive Director to enhance strategic oversight amidst ongoing succession planning initiatives.

Dive into the specifics of Neometals here with our thorough balance sheet health report. Review our historical performance report to gain insights into Neometals' track record.ASX:NMT Financial Position Analysis as at Jan 2026

Turning Ideas Into Actions

Take a closer look at our  ASX Penny Stocks list of 412 companies by clicking here. Seeking Other Investments? Outshine the giants: these 24 early-stage AI stocks could fund your retirement.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ASX:APX ASX:CXL and ASX:NMT.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments